Half Year 2026 Dbv Technologies SA Earnings Call Transcript
Welcome to the DBV second-quarter 2026 results and business update conference call. (Operator Instructions) Please note this event is being recorded.
I would now like to turn the conference over to Jonathan Neely, Investor Relations. Please go ahead, sir.
Thank you. Good afternoon. DBV Technologies reported financial results for the second quarter and half year of 2026. This update is available in the Press Releases section of the DBV Technologies website.
Before we begin, please note that today's call may include a number of forward-looking statements, including, but not limited to, comments regarding our forecast of estimated cash runway, clinical and regulatory development plans, the design and conduct of our clinical trials, the timing and the results of interactions with regulatory agencies, and the ability of any of our product candidates, if approved, to improve the lives of patients with food allergies.
These forward-looking statements are based on assumptions that are
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
